A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine

Multiple sclerosis (MS) is an auto-immune mediated neurological disorder that affects the central nervous system and leads to myelin sheath destruction. The pathogenesis of MS involves T helper cells causing inflammation and eventual death of the oligodendrocytes. Etiologies for the development of M...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ariana R. Tagliaferri, George Horani, Katherine Stephens, Patrick Michael
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2021
Materias:	covid-19 pfizer vaccine multiple sclerosis weakness tia Internal medicine RC31-1245
Acceso en línea:	https://doaj.org/article/1d47a581a9f5442980f1fc45f9bdf5df
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1d47a581a9f5442980f1fc45f9bdf5df
record_format	dspace
spelling	oai:doaj.org-article:1d47a581a9f5442980f1fc45f9bdf5df2021-11-17T14:21:57ZA rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine2000-966610.1080/20009666.2021.1979745https://doaj.org/article/1d47a581a9f5442980f1fc45f9bdf5df2021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/20009666.2021.1979745https://doaj.org/toc/2000-9666Multiple sclerosis (MS) is an auto-immune mediated neurological disorder that affects the central nervous system and leads to myelin sheath destruction. The pathogenesis of MS involves T helper cells causing inflammation and eventual death of the oligodendrocytes. Etiologies for the development of MS include a combination of genetic, environmental, and immune factors. Vaccines have been proposed to increase the immune response and have reportedly activated some autoimmune disorders. Although certain vaccines such as hepatitis B have been associated with MS, studies have refuted these cases. We present a rare case of a 32-year-old patient who presented with symptoms and suggestive of MS a few days after receiving the COVID vaccine. Laboratory and imaging findings confirmed the diagnosis of MS, and she was started on steroids and discharged in a stable condition a few days after.Ariana R. TagliaferriGeorge HoraniKatherine StephensPatrick MichaelTaylor & Francis Grouparticlecovid-19pfizer vaccinemultiple sclerosisweaknesstiaInternal medicineRC31-1245ENJournal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 6, Pp 772-775 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	covid-19 pfizer vaccine multiple sclerosis weakness tia Internal medicine RC31-1245
spellingShingle	covid-19 pfizer vaccine multiple sclerosis weakness tia Internal medicine RC31-1245 Ariana R. Tagliaferri George Horani Katherine Stephens Patrick Michael A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
description	Multiple sclerosis (MS) is an auto-immune mediated neurological disorder that affects the central nervous system and leads to myelin sheath destruction. The pathogenesis of MS involves T helper cells causing inflammation and eventual death of the oligodendrocytes. Etiologies for the development of MS include a combination of genetic, environmental, and immune factors. Vaccines have been proposed to increase the immune response and have reportedly activated some autoimmune disorders. Although certain vaccines such as hepatitis B have been associated with MS, studies have refuted these cases. We present a rare case of a 32-year-old patient who presented with symptoms and suggestive of MS a few days after receiving the COVID vaccine. Laboratory and imaging findings confirmed the diagnosis of MS, and she was started on steroids and discharged in a stable condition a few days after.
format	article
author	Ariana R. Tagliaferri George Horani Katherine Stephens Patrick Michael
author_facet	Ariana R. Tagliaferri George Horani Katherine Stephens Patrick Michael
author_sort	Ariana R. Tagliaferri
title	A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
title_short	A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
title_full	A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
title_fullStr	A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
title_full_unstemmed	A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
title_sort	rare presentation of undiagnosed multiple sclerosis after the covid-19 vaccine
publisher	Taylor & Francis Group
publishDate	2021
url	https://doaj.org/article/1d47a581a9f5442980f1fc45f9bdf5df
work_keys_str_mv	AT arianartagliaferri ararepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine AT georgehorani ararepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine AT katherinestephens ararepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine AT patrickmichael ararepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine AT arianartagliaferri rarepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine AT georgehorani rarepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine AT katherinestephens rarepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine AT patrickmichael rarepresentationofundiagnosedmultiplesclerosisafterthecovid19vaccine
_version_	1718425467100332032

A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine

Ejemplares similares